Biological therapies serve as a treatment option for autoimmune and inflammatory conditions. In this Clinic Minute, Elizabeth Duruz, a Certified Specialty Pharmacist and Clinical Programs Manager at CSI, explains what biological therapies are and their significance. If you have any questions, drop them in the comments and our team will be happy to assist you.
CSI Pharmacy’s Post
More Relevant Posts
-
SMS Clinical Research is inviting individuals diagnosed with Psoriasis to participate in a new clinical trial. This is an opportunity to contribute to groundbreaking research that could lead to new treatments. Your experience could be invaluable in helping others. If you're interested in participating or want more information, visit https://lnkd.in/ghBtfXny. #Psoriasis #HealthResearch #JoinNow #SMSResearch #Rewards #Trials #ClinicalTrials #ClinicalStudy #PositiveChange #Medical #Medicine #Research #Technology #LatestStudy #SMSClinicalResearch #MesquiteTX
-
-
Consultant Physician and Endocrinologist MBBS (Hons), MRCP(UK), MRCP(Endocrinology), FRCP(Edin), FRCP(London) CCT in GIM, Diabetes & Endocrinology
A quick overview for ADA 2024 SOC ..
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
-
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
-
The introduction of S1P receptor modulators and JAK inhibitors for Ulcerative Colitis has the potential to revolutionize the therapeutic landscape. Yes, it’s true. Interested in learning more? Join us as expert faculty discuss the place in therapy for these agents to help improve clinical and patient-oriented health outcomes. Register: https://lnkd.in/g6Rz8K4b #improvepatientoutcomes #cme
-
-
🧐We welcome you to read "Fatigue: #Pharmacological and non-pharmacological management in patients with multiple #sclerosis" 👥By Kubra Yeni et al. Read #article here: https://lnkd.in/gcz6RifC
-
-
There is a very strong correlation between the understanding of the genetic basis of medical conditions and the development of new therapeutic options for patients. #clinicalgenetics #healthcare #humangenetics #medicalgenetics #medicine #precisionmedicine
-
Toxic Nephropathies of the Tubulointerstitium: Core Curriculum 2024 AJKD Published: January 19, 2024 DOI:https://lnkd.in/dzH4bwb9 In this Core Curriculum, mechanisms of common toxin-induced tubulointerstitial renal injury and review their causes, clinical presentations, diagnosis, and management.
-
-
The first-of-its-kind therapeutic approach from SetPoint Medical targets pathways intended to promote remyelination in those with relapsing-remitting #multiplesclerosis.
Breakthrough Device Designation Granted to SetPoint Medical's Multiple Sclerosis Treatment
-
Review an interactive resource summarizing data from an ongoing Phase 3 clinical study evaluating the long-term efficacy and safety profile of an oral therapy for the treatment of patients with moderate-to-severe #AtopicDermatitis (AD). View the results of this planned interim analysis here: https://lnkd.in/eAWVupuJ
Long-term efficacy and safety profile of an oral therapy for moderate-to-severe AD
